VANCOUVER, BC, May 30, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. Panasonic Corp (spons. PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG. PanGenomic Health Inc. PanGenomic Health Inc. Victoria Community Health Co-operative, Victoria, British Columbia. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Seite 1 der Diskussion 'Wird PanGenomic Health der neue Star am Mobile Medical. CSE) on Friday announced the soft launch of thePanGenomic offers a self-care digital platform to deliver personalized, evidence-based information about natural and plant-based health treatments, according to the company. 026, 22. VANCOUVER, BC, Nov. Discover historical prices for NARA. 216 Euro. has been appointed as the Company's AQSE Corporate Adviser. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. Other stock markets. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere. ("PlantGx"), has signed a development partnership. Last Funding Type Post-IPO Equity. Nachrichten zur Aktie Microsoft Corp. Stock Symbol CNSX:NARA. Here, we use an automated pipeline of human pangenomic analysis to build gastric. Pangenomic Health Inc. 0201, set on Aug 23, 2023. The. 107,68. 12 April 2022. President & CEO. Unternehmens-Meldungen im Überblick: Auf dieser Seite finden Sie alle Finanznachrichten zu Unternehmen in chronologischer Reihenfolge. Love this for my natural remedy guide I never know what I should get or how to use it and Nara does that all for me perfectly. According to the National Institute of Mental Health Disorders, an estimated 26% of adults ages 18 and older suffer from a diagnosable mental disorder in a given year. 09:30:00 2023-10-31 am EDT 5-day change. 21, 2022 /CNW/ - PanGenomic Health Inc. ADRs) 21Vianet Group Inc. euro stoxx 50. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health Inc. View the latest PanGenomic Health Inc. 30 Day Avg Volume 115,910. Lesen Sie Börsennachrichten und Hintergründe zum Aktienmarkt in Deutschland und der ganzen Welt. NARA Date: December 23, 2022 Is this an updating or amending Notice: Yes No If yes provide date(s) of prior Notices: Issued and Outstanding Securities of Issuer Prior to Issuance: 93,040,972 Pricing Date of news release announcing proposed issuance: N/A orPanGenomic Health Aktie, WKN: A3DN26, ISIN: CA69842E2050 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen In Ihrem Browser ist JavaScript deaktiviert. Stock | Canadian Securities Exchange: NARA | Canadian Securities ExchangeStocks in play: PanGenomic Health Inc. 2. For further information: Jerry Lai, Investor Relations, PanGenomic Health Inc, 778 743 4642, ir@pangenomic. CA24463V1013. com. Tweets & replies. Company Type Non-profit. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic. PanGenomic Health Inc. Pangenomic Health A Realtimekurs. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic ISIN CA69842E2050. care. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. CA69842E2050. 325. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Earnings Per Share-0. com This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by. Aktienchart mit vielen Chartindikatoren & Vergleichsmöglichkeiten inkl. (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders (2022-12-22 | CSE:NARA) PanGenomic Health Issues Letter to Shareholders. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. Zuletzt verteuerte sich das. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 04 CAD. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. +0,45 %. The Company's initial. 0. Company profile page for PanGenomic Health Inc including stock price, company news, press releases, executives, board members, and contact informationWe would like to show you a description here but the site won’t allow us. VANCOUVER, BC, Nov. Notre objectif initial est la santé mentale. Die Pangenomic Healt a-Aktien notieren unter der WKN bzw. Equities NARA CA69842E2050 Advanced Medical Equipment & Technology Delayed Canadian Securities Exchange. 9, 2023 /CNW/ - PanGenomic Health Inc. As well, Fobi reported that it has granted, pursuant to its Stock Option Plan, a total of 3,814,892 stock options to several company employees and officers to purchase. Tweets. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social. +/-%. PanGenomic Health Inc. news services or for dissemination in the United States /. David Joshua Bartch is an entrepreneur and businessperson who founded Doctors Orders LLC, Audiotranscriptionist Com and Revolutionary Software LLC and who has been at the helm of 7 different companies. It develops the Nara App, a mental health app that curates natural remedies for individuals to manage and improve mental wellness; Mindleap, a mental health tracker that offers access to audio content, blogs, and professional services for mental well-being; and MUJN that offers. (“IHI”), whereby PanGenomic Health will license IHI’s. Pangenomic Health Inc. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. ISIN. VANCOUVER, BC, Nov. EPS -0. Dear Shareholders, As we. 0500. Pangenomic Health Inc. Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc. marktüblicher Spreads)! Nachrichten zur PANGENOMIC HEALTH A Aktie - Aktuelle TOP-Meldungen - Die wichtigsten PANGENOMIC HEALTH A News im Überblick - seriös, schnell und kompetent. As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry. Signs Non-Binding Letter of Intent for an Exclusive Special Purpose Licence of the Cyberpatient Ai Medical Education Platform May. 23, 2022 /CNW/ - PanGenomic Health Inc. 0500. 22, 2022 /CNW/ - PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its subsidiary, MUJN Diagnostics Inc. -0,87%. (NARA. N-N6kQrkeXBQV39vtKCgMFC0uimY_VLCNyX7dlB17Y8. Chance: Fundamentalanalyse Risikoanalyse Alternativen. 1, 2023 /CNW/ - PanGenomic Health Inc. The Company's initial focus is to support mental health. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce platform on nara. PanGenomic Health Inc. 28: CI Pangenomic Health Inc. All markets data located on FT. Pangenomic Health will provide further updates on its application to list on the AQSE when available. CA2684692023. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. Pangenomic study might improve the completeness of human reference genome (GRCh38) and promote precision medicine. Pangenomic Health Inc (LL30:HAM) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth. care will market its. operates as a precision health company. ("Mindleap") from Mydecine Innovations Group. The Quality Forum provides. 30: AN Pangenomic Health Inc. Kurs. WKN. care will market its proprietary natural herbal remedy information. Find companies based on country, sector, and other equity characteristics. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. PanGenomic Health, Inc. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health Inc. Earnings vs Industry: NARA is unprofitable, making it difficult to compare its past year. BDNF levels. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed its audited annual financial statements for the fiscal year ended. $1. PanGenomic is a health-tech company with an AI platform that supports consumer applications offering Telehealth, and diagnostic tools designed to improve quality and accessibility of care for. 25 Tage Jubiläumsparty: Jetzt mitmachen und täglich neue Gewinnchance sichern. A3DN26. 778 743 4642 778 743 4642. This news release includes certain statements that may be deemed “forward-looking statements”, including statements respecting the services to be provided by PanGenomic and the. PanGenomic Health Inc. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, Jan. Es liegen keine Schätzungen zu dieser Aktie vor. 0,0201. The company was founded by Robert Nygren and Vincent Lum on. PanGenomic Health Inc. Pangenomic Health Inc. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. PanGenomic Health Inc. Exchange Traded Funds (ETFs): Hier finden Sie eine Übersicht über alle handelbaren ETFs, ETF Suche, ETF Vergleiche und Analysen. Juni 2023 29. Pangenomic Health Inc. . Pangenomic Health Inc. PanGenomic Health (NARA) share price, charts, trades & the UK's most popular discussion forums. The company was founded by Robert Nygren and Vincent Lum on December 11, 2015 and is headquartered in Vancouver, Canada. The Company's initial focus is to support mental health. VANCOUVER, BC, Jan. ±0. 57. | 880206 | CAH | US14149Y1082. In addition, PanGenomic has engaged Generation IACP Inc. Presently, Mr. 62%. Le 15 juillet/July 2022. Our initial focus. (“Meus”) to provide capital markets advisory, investor relations and corporate strategy services. Jan 23, 2023. PanGenomic Health Inc. Die folgenden Aktien aus der Peer Group von Pangenomic Health A haben eine. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. 21, 2022 at 12:07 p. On Tuesday, Pangenomic Health Inc (LL30:FRA) closed at 0. com Maryam Marissen, President & CEO. Together, we are working on a family of products that address significant gaps in healthcare, spanning mental health support, conventional treatment. PanGenomic Health Inc. The LOI contemplates that the Pangenomic will acquire all of Mindleap's outstanding shares for a purchase price of. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science. Primary Industries. View real. com. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. Not for distribution to U. VANCOUVER, BC, March 8, 2023 /CNW/ - PanGenomic. | CA69842E2050. announced that, further to the announcement made on January 9, 2023, the Company has launched its new visual identity, website and e-commerce store for its NARA brand, available at nara. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. EVAHF. (NARA. PanGenomic Health Inc. PANGENOMIC HEALTH INC. PanGenomic Health Inc. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission. from Mydecine Innovations Group Inc. ("MUJN Diagnostics"), has launched its BDNF (brain. Find the latest Pangenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. 0,0224. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app. The firm's products includ Nara App and PlantGx Platform. ISIN. 2 Ratings. Kursentwicklung, News & Analysen. ("Hemex Health"), a Portland, Oregon-based medical diagnostic device company focused on developing life. VANCOUVER, BC, Jan. 17 Following. Registered as a British Columbia benefit company, Pangenomic Health's mission is to promote and improve the health. ISIN. VANCOUVER, BC, May 2, 2023 /CNW/ - PanGenomic Health Inc. is a precision health company. PanGenomic Health will purchase Mindleap Health for approximately $3 million. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. New look and feel! Ratings and Reviews 5. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 64% above the 52 week low of 0. Push Kurse werden börsentäglich von 8:00 bis 23:00 Uhr, samstags von 10:00 bis 13:00 Uhr und sonntags von 17:00 bis 19:00 Uhr aktualisiert. , a Santa Clara-based medical device company ("LumiQuick "). est une entreprise de santé de précision qui a développé une plateforme numérique d'auto-soins pour fournir des informations personnalisées et fondées sur des preuves sur les traitements naturels. The two companies are jointly developing targeted biomarker diagnostics to help patients undergoing. 22, 2022 /CNW/ - PanGenomic Health Inc. kündigt. 1,089 likes · 16 talking about this. PANGENOMIC HEALTH A Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A3DN26 - CA69842E2050 - Realtimekurse VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. Stocks. View daily, weekly or monthly format back to when Pangenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission. About PanGenomic Health. PANGENOMIC HEALTH A Insidertrades - hier finden Sie eine Übersicht über alle veröffentlichungspflichtigen Insidertrades von PANGENOMIC HEALTH A (Vorstand, Aufsichtsrat usw. Medizinische Software & Technologie-Dienstleistungen. Portfolio Tracking Watchlists Märkte Dividendenkalender Neu Community Blog Registrieren Anmelden Aktie. PanGenomic Health, Inc. CN) with historical highs & lows, new high & low prices, past performance, latest news. PANGENOMIC HEALTH A Times and Sales - hier finden Sie eine Übersicht über die Käufe und Verkäufe (Umsätze) mit Uhrzeit und Volumen der PANGENOMIC HEALTH A Aktie an allen Börsenplätzen. Own your health journey . Latest Pangenomic Health Inc (LL30:FRA) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and. PanGenomic Health Inc - PanGenomic Health Announces Financial Results for Half Year Ended 30 June 2023Latest Analyst Research & Price Targets for Pangenomic Health Inc. PANGENOMIC HEALTH A Chart - ein übersichtlicher, großer Chart der PANGENOMIC HEALTH A Aktie. 00; Net income in CAD-12. Loading more data. ftse-100 PANGENOMIC HEALTH A Analysen - hier finden Sie eine Übersicht aller relevanter Aktienanalysen zur PANGENOMIC HEALTH A Aktie von Banken, Investmenthäusern und Medien. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Colin Quon. ADRs) | 909800 | TSM | US8740391003Pangenomic Health Registered (A) Kurs heute • Aktuelle Realtime Finanzdaten, Nachrichten und Informationen zur Aktie • CA69842E2050 •Pangenomic Health Inc. We believe that mental health and physical wellbeing should not be a luxury, but a basic human. VANCOUVER, BC, Jan. PanGenomic Health Inc. PanGenomic Health Inc. (formerly named PlantGx Diagnostics Corp. Official Data Partner. DEFENCE THERAPEUTICS A AKTIE und aktueller Aktienkurs. Share your opinion and gain insight from other stock traders and investors. Take a look at our analysis of LL30’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. 0212 set on Aug 22, 2023. Mit der TradingView Desktop Anwendung können Sie sich mit Ihrem Browser bei Ihrem Konto anmelden und alle Funktionen nutzen. 23. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that it plans to launch its e-commerce platform for personalized natural health solutions this month. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed. . MICROSOFT AKTIE und aktueller Aktienkurs. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PANGENOMIC HEALTH A Chartanalyse und Chartsignale - Entwicklung Long-Short Ratio PANGENOMIC HEALTH A Aktie - Alle Signale verschiedener Trading-StrategienPanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomicISIN CA69842E2050. A3CN14. *Close price adjusted for splits. Dear Shareholders, As we. Popular. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. com; Maryam Marissen, President & CEO, PanGenomic Health Inc. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Pangenomic Health regulatory filings. CN stock on Yahoo Finance. Der Schlusskurs der Aktie betrug am vorangegangen Handelstag 75,18 USD. The Company's initial. 15. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Latest Trade. 778 743 4642 778 743 4642. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce the results of its Annual. Anzeige. PanGenomic Health Inc. 11. David Coffman / George Duxberry. ("PanGenomic") (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. F) stock discussion in Yahoo Finance's forum. Forum; Börsenspiel; ARIVA. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that Maryam Marissen has been. Own your health journey. PanGenomic is a healthtech company on a mission to offer effective and accessible tools that transform the status quo in the world of mental and physical health. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that its subsidiary, MUJN Diagnostics. m. Under the terms of the agreement, Bello will provide a combination of capital. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. The Company's initial. Zu den erfolgreicheren Aktien des Tages zählt am Montagvormittag der Anteilsschein von Pangenomic Health A. CN stock on Yahoo Finance. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. Er übernimmt die ETF-Auswahl, ist steuersmart. What’s New. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Porsche Automobil vz. Analyst Potential (Euro) Potential Zeit; Aktuell sind keine Analysen verfügbar, die den gewählten Kriterien entsprechen. from Mydecine Innovations Group Inc. *Close price adjusted for splits. To view PanGenomic Health’s complete subsidiaries history, request access ». ca). PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. | CA69842E2050. 58,940. Company Profile. 07. A publicly-traded benefit corporation (CSE:NARA). (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform to deliver. Get the latest Pangenomic Health Inc. The Company released a new version of its. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. David Coffman / George Duxberry. (CNSX:NARA) signed an arm's length non binding Letter of Intent to acquire Mindleap Health Inc. PanGenomic Health Inc. Public Health Association of BC: PHABC, Victoria, BC. PANGENOMIC HEALTH A Schätzungen: Hier finden Sie einen Überblick über die erwartete Entwicklung der wichtigsten Kennzahlen. 30 Day Avg Volume 100,118. ca VANCOUVER, BC, March 28, 2023 /CNW/ - PanGenomic Health Inc. Alle Nutzer können den Diskussionen auf Investing. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 30. )("MUJN Diagnostics"), has signed a non-binding memorandum of understanding ("MoU") for a diagnostic testing joint venture with Psy Integrated Health. info@chatnels. Er kritisiert die Aktie als klinisch tot und verwirft Vorwürfe gegen den CEO, der seine Scheine laufen lässt. VANCOUVER, BC, Dec. The patent-pending LivNao IP includes technology which combines smartphone sensor data and. 04/05/2023 08:04:49 Cookie Policy +44 (0) 203 8794 460. Company Profile. 778 743 4642. Die Nutzung der comdirect-Website ist ohne JavaScript nicht möglich. All values updated annually at fiscal year end. (dba Bello Capital Partners) 310 Water Street, Suite 306. Shares Outstanding 71. PanGenomic Health has raised a total of. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to provide an update on its NARA product and announce that it. CA69842E2050. 0. PanGenomic Health Inc. 778 743 4642. ("PlantGx"), has signed a development partnership agreement with LumiQuick Diagnostics, Inc. PanGenomic Health Inc - PanGenomic Health Intends to Close Shares for Debt Settlement PR Newswire LONDON, United Kingdom, November 02 2 November 2023 PanGenomic Health. reported earnings results for the third quarter and nine months ended September 30, 2022. (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform. PANGENOMIC HEALTH A Times and Sales - hier finden Sie eine Übersicht über die Käufe und Verkäufe (Umsätze) mit Uhrzeit und Volumen der PANGENOMIC HEALTH A Aktie an allen Börsenplätzen. . euro stoxx 50. (A) (spons. Pangenomic Health-Aktie (NARA) Forum: Teilen Sie hier Ihre Meinungen und Trading-Ideen. Vincent Lum CEO and Director at Pangenomic Health- Helping individuals take control of their health by providing personalized information (based on your needs, and biomarkes) on the use of plant. Investor Help Forum;06 Sep, 2022, 19:17 ET. provided an update on its NARA product and announce that it is planning to launch Conversational AI for the NARA app and web platform . 38%. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that,. 778 743 4642. As we close out our first year as a publicly-traded company, your team at PanGenomic Health is busy laying the groundwork for success in the burgeoning health technology industry. . 4% per year. 08%. EUR. MYDECINE INNOVATIONS Group Inc. CI Pangenomic Health Inc. Artikel lesen 01. Potential. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. Perf. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments.